Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.94

-0.7%

3:01 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (751)	3/5/2000 11:22:00 PM
From: Dave K	of 52153

Peter, >> Music to the ears of MABA Yes on 103, but don't forget 205. Pharmas: I'm trying to figure their future as well. Supposedly a negotiated compromise with Gov is: more patients covered will make up for a shortfall in drug prices. Pharmas resurfaced from the first term Clinton threat quite nicely in early '90s. I don't want to miss a second round but their expiring patents on high $ drugs is concern this time. With pharmaceutical costs rising at 25% p.a. now + comsumer/healthcare/legislation groups pushing hard for lowering brand prices - I'm counting on Drug Delivery & Generics to be looked at to help the crisis. Lot's of talk about "leveling the playing field" for Generics. Generic competition is very aggressive right now but a few cos have been very kind so far: ADRX, BVF, SKYE, ELAN, KING. (& let's not forget SEPR !)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next